Certification Practice Exam (2026/2027) – Board
Review & Comprehensive Assessment | A+
Predictor Questions
ANCC Blueprint-Aligned Predictive Assessment | 75 Questions with
Psychometric Rationales
Exam Specifications:
● Total Questions: 75
● Domain I (Assessment & Diagnosis): 23 questions (31%)
● Domain II (Plan of Care & Implementation): 23 questions (31%)
● Domain III (Evaluation & Professional Role): 19 questions (25%)
● Domain IV (NP-Patient Relationship): 10 questions (13%)
DOMAIN I: ASSESSMENT AND DIAGNOSIS (31% - 23 Questions)
Q1.
A 24-year-old sexually active female presents with a 3-day history of dysuria, frequency,
and suprapubic discomfort. She has no fever, flank pain, or vaginal discharge. Urine
dipstick in the office is positive for leukocyte esterase and nitrites. She reports a true
allergy to sulfa drugs (previous Stevens-Johnson reaction).
What is the MOST appropriate next step in management?
A. Prescribe trimethoprim-sulfamethoxazole DS twice daily for 3 days.
,B. Obtain a urine culture and susceptibility and initiate empiric therapy with
nitrofurantoin monohydrate 100 mg twice daily for 5 days.
C. Order a renal ultrasound to rule out pyelonephritis.
D. Refer to urology for cystoscopy due to concern for recurrent infection.
Graded A 100% Correct Answer: B
Psychometric Rationale:
ANCC Domain & Task Mapping: This item maps to ANCC Domain I: Assessment and
Diagnosis, Task: "Select and interpret diagnostic studies to formulate differential
diagnoses and guide clinical decision-making."
Evidence-Based Justification: The 2026 IDSA Guidelines for Uncomplicated Urinary
Tract Infection recommend obtaining a urine culture in patients with allergies to first-line
agents (like sulfa drugs) to guide targeted therapy. Nitrofurantoin is a recommended
first-line alternative for uncomplicated cystitis and is appropriate pending culture
results. Empiric treatment without a culture (Option A) is contraindicated given her
severe allergy history.
Clinical Decision Pathway:
● Key Cue 1: Symptoms of uncomplicated cystitis (dysuria, frequency, suprapubic
pain without fever/flank pain)
● Key Cue 2: Positive dipstick (leukocyte esterase + nitrites) confirms infection
● Key Cue 3: Life-threatening sulfa allergy (Stevens-Johnson reaction)
● Clinical Principle: When first-line therapy is unsafe, culture-guided therapy is
standard to ensure efficacy and prevent antibiotic resistance. Nitrofurantoin
provides safe, empiric coverage for common uropathogens.
Distractor Analysis:
, ● A: Therapeutic Error & Safety Violation. Prescribing a medication to which the
patient has a life-threatening allergy is a critical error that could result in fatal
hypersensitivity reaction. This represents catastrophic clinical judgment failure.
● C: Unnecessary Diagnostic Testing (Diagnostic Overshoot). Lacks indications for
pyelonephritis (fever, flank pain, CVA tenderness); ultrasound is not indicated for
simple cystitis and represents resource misuse.
● D: Failure to Manage & Inappropriate Referral (Scope Evasion). Referral is not
indicated for a first, uncomplicated UTI; this represents a failure to treat within
the FNP scope and unnecessary healthcare expenditure.
Certification Insight: "Management of common conditions must always be modified by
patient-specific factors, such as drug allergies. When first-line therapy is contraindicated,
obtaining cultures to guide targeted treatment becomes a standard of care, not an
optional step."
Q2.
A 58-year-old Black male with hypertension, type 2 diabetes (HbA1c 7.8%), and a
40-pack-year smoking history presents for his annual Medicare wellness visit. His BP is
136/82 mmHg, BMI 31 kg/m². He reports no chest pain or dyspnea. On examination,
you note a 5 mm convex, pigmented lesion on the right helix with irregular borders and
peppering. The patient states it has been present "for years" but seems darker recently.
Which screening or diagnostic action is MOST evidence-based?
A. Reassure the patient and continue annual skin examination
B. Order low-dose CT chest scan for lung cancer screening today
C. Perform a 4-mm punch biopsy of the helix lesion
D. Schedule total-body photography in 6 months for surveillance
Graded A 100% Correct Answer: C
, Psychometric Rationale:
ANCC Domain & Task Mapping: This item maps to ANCC Domain I: Assessment and
Diagnosis, Task: "Identify red-flag findings requiring urgent diagnostic work-up."
Evidence-Based Justification: The 2027 USPSTF Recommendation Statement on Skin
Cancer Screening and American Academy of Dermatology consensus guidelines
indicate that ABCDE changes (Asymmetry, Border irregularity, Color variation, Diameter
>6mm, Evolution) in high UV-exposure sites on high-risk phenotypes warrant immediate
biopsy, not observation. The helix is a high sun-exposure site; irregular borders plus
peppering (regression) are melanoma red flags.
Clinical Decision Pathway:
● Key Cue 1: Irregular borders + peppering (regression) = melanoma features
● Key Cue 2: High-risk phenotype (Black male with significant UV exposure—helix
site)
● Key Cue 3: Recent change (evolution) in pigmented lesion
● Clinical Principle: Any pigmented lesion with ABCDE criteria in high-risk patients
requires histopathologic diagnosis; clinical observation is indefensible.
Distractor Analysis:
● A: Anchor Bias & False Reassurance. Ignoring objective melanoma red flags due
to patient report of long-standing presence; evolution (darkening) is a critical
warning sign.
● B: Context Switch Error. LDCT is appropriate for lung cancer screening given
smoking history, but this distractor redirects attention away from the immediate
dermatologic red flag requiring action today.
● D: Delay & Misallocation (Surveillance Bias). Total-body photography is
surveillance for patients with numerous atypical nevi, not diagnostic for a
specific suspicious lesion; delay risks melanoma progression.